Universitätsklinikum Leipzig

Prevalence and prognostic role of thoracic lymphadenopathy in Covid-19. (2025) Sähn MJ, Wienke A, Meyer HJ, Dietz J, Vogl TJ, Borggrefe J, Gussew A, et al. Journal article Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025) Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al. Journal article Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg. (2025) Kött J, Zell T, Zimmermann N, Rünger A, Smit DJ, Abeck F, Geidel G, et al. Journal article The prognostic relevance of pleural effusion in patients with COVID-19 - A German multicenter study (2025) Bucher AM, Dietz J, Ehrengut C, Müller L, Schramm D, Akinina A, Drechsel M, et al. Journal article Prognostic value of CT-defined coronary sclerosis in COVID-19: Results of a multicenter study based on the Weston score (2025) Bucher AM, Frodl E, Ehrengut C, Müller L, Emrich T, Kloeckner R, Sieren M, et al. Journal article VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML (2025) Kretschmer L, Ruhnke L, Schliemann C, Fransecky L, Steffen B, Kaufmann M, Burchert A, et al. Journal article Multicenter multiplatform pattern-of-practice analysis of single-isocenter multitarget stereotactic radiosurgery (2025) Thomann B, Fechter T, Fischer J, Runz A, Roers J, Ludwig U, Grehn M, et al. Journal article Guideline-recommended basic parameter adherence in neurocritical care stroke patients: Observational multicenter individual participant data analysis. (2025) Mrochen A, Alhaj Omar O, Pelz JO, Michalski D, Neugebauer H, Lehrieder D, Knier B, et al. Journal article Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis (2025) Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerová B, Šrámek J, Valka J, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article